Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Lachnospira multipara strain:D15d

ABSTRACT: Lachnospira multipara D15d genome sequencing

PROVIDER: PRJNA322956 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR4218896_1.fastq.gz	Fastqsanger.gz
	SRR4218896_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Lachnospira multipara

Project description:Lachnospira multipara overview

| PRJNA186712 | ENA

Lachnospira multipara MC2003

Project description:Lachnospira multipara MC2003 Genome sequencing and assembly

| PRJNA223474 | ENA

Lachnospira multipara LB2003

Project description:Lachnospira multipara LB2003 Genome sequencing and assembly

| PRJNA223491 | ENA

Lachnospira multipara ATCC 19207

Project description:Lachnospira multipara ATCC 19207

| PRJNA185693 | ENA

Lachnospira pectinoschiza strain:M83

Project description:Lachnospira pectinoschiza M83 genome sequencing

| PRJNA322957 | ENA

Lachnospira pectinoschiza strain:M46

Project description:Lachnospira pectinoschiza M46 genome sequencing

| PRJNA334926 | ENA

Project description:Lachnospira multipara D15d

| PRJEB16720 | ENA

Lachnospira pectinoschiza

Project description:Lachnospira pectinoschiza overview

| PRJNA342878 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

E-GEOD-18068

Project description:Genome-wide transcriptome sequencing at different stages of Drosophila melanogaster development, RNA-seq

2020-07-22 | E-GEOD-18068 | ExpressionAtlas